Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 2.437
Filter
1.
J Infect Dev Ctries ; 18(4): 495-500, 2024 Apr 30.
Article in English | MEDLINE | ID: mdl-38728633

ABSTRACT

INTRODUCTION: After the Coronavirus Disease 2019 pandemic, a high number of cases and severe dengue in children were reported in some provinces in the south of Vietnam. This study aimed to determine the distribution of dengue virus serotypes and their correlation with demographic factors, disease severity, clinical manifestations, and laboratory findings. METHODOLOGY: This study employed a cross-sectional design. Ninety-six dengue-infected children admitted to Can Tho Children's Hospital between October 2022 and March 2023 were included. Confirmation of dengue infection was achieved through the real-time polymerase chain reaction (RT-PCR). RESULTS: Among the identified serotypes, DENV-2 accounted for the highest proportion (71.87%), followed by DENV-1 (23.96%), and DENV-4 (4.17%). DENV-3 was not detected. No significant demographic, disease severity, or laboratory differences were observed among the identified dengue serotypes. However, DENV-2 was associated with a higher occurrence of mucous membrane hemorrhages and gastrointestinal bleeding compared to other serotypes. CONCLUSIONS: Although DENV-2 was the most prevalent serotype responsible for dengue in children in southern Vietnam, it did not lead to more severe cases compared to other serotypes. This finding is crucial for evaluating the illness's prognosis.


Subject(s)
Dengue Virus , Serogroup , Severe Dengue , Humans , Vietnam/epidemiology , Severe Dengue/epidemiology , Severe Dengue/virology , Cross-Sectional Studies , Male , Dengue Virus/classification , Dengue Virus/genetics , Dengue Virus/isolation & purification , Female , Child , Child, Preschool , Adolescent , Infant , Severity of Illness Index
2.
Euro Surveill ; 29(20)2024 May.
Article in English | MEDLINE | ID: mdl-38757289

ABSTRACT

Aedes albopictus collected in 2023 in the greater Paris area (Île-de-France) were experimentally able to transmit five arboviruses: West Nile virus from 3 days post-infection (dpi), chikungunya virus and Usutu virus from 7 dpi, dengue virus and Zika virus from 21 dpi. Given the growing number of imported dengue cases reported in early 2024 in France, surveillance of Ae. albopictus should be reinforced during the Paris Olympic Games in July, when many international visitors including from endemic countries are expected.


Subject(s)
Aedes , Chikungunya virus , Dengue Virus , Zika Virus , Animals , Aedes/virology , Humans , Zika Virus/isolation & purification , Dengue Virus/isolation & purification , Chikungunya virus/isolation & purification , Paris , Mosquito Vectors/virology , West Nile virus/isolation & purification , Arboviruses/isolation & purification , Arbovirus Infections/transmission , Flavivirus/isolation & purification , France , Dengue/transmission , Dengue/epidemiology , Zika Virus Infection/transmission
3.
BMC Genomics ; 25(1): 433, 2024 May 01.
Article in English | MEDLINE | ID: mdl-38693476

ABSTRACT

BACKGROUND: The increasing burden of dengue virus on public health due to more explosive and frequent outbreaks highlights the need for improved surveillance and control. Genomic surveillance of dengue virus not only provides important insights into the emergence and spread of genetically diverse serotypes and genotypes, but it is also critical to monitor the effectiveness of newly implemented control strategies. Here, we present DengueSeq, an amplicon sequencing protocol, which enables whole-genome sequencing of all four dengue virus serotypes. RESULTS: We developed primer schemes for the four dengue virus serotypes, which can be combined into a pan-serotype approach. We validated both approaches using genetically diverse virus stocks and clinical specimens that contained a range of virus copies. High genome coverage (>95%) was achieved for all genotypes, except DENV2 (genotype VI) and DENV 4 (genotype IV) sylvatics, with similar performance of the serotype-specific and pan-serotype approaches. The limit of detection to reach 70% coverage was 10-100 RNA copies/µL for all four serotypes, which is similar to other commonly used primer schemes. DengueSeq facilitates the sequencing of samples without known serotypes, allows the detection of multiple serotypes in the same sample, and can be used with a variety of library prep kits and sequencing instruments. CONCLUSIONS: DengueSeq was systematically evaluated with virus stocks and clinical specimens spanning the genetic diversity within each of the four dengue virus serotypes. The primer schemes can be plugged into existing amplicon sequencing workflows to facilitate the global need for expanded dengue virus genomic surveillance.


Subject(s)
Dengue Virus , Genome, Viral , Serogroup , Whole Genome Sequencing , Dengue Virus/genetics , Dengue Virus/isolation & purification , Dengue Virus/classification , Whole Genome Sequencing/methods , Humans , Genotype , Dengue/virology , Dengue/diagnosis , High-Throughput Nucleotide Sequencing/methods , RNA, Viral/genetics
6.
J Vector Borne Dis ; 61(1): 61-71, 2024 Jan 01.
Article in English | MEDLINE | ID: mdl-38648407

ABSTRACT

BACKGROUND OBJECTIVES: Dengue and chikungunya infections are one of the major health problems that have plagued the human population globally. All dengue virus (DENV) serotypes circulate within Malaysia with particular serotypes dominating in different years/outbreaks. In the state of Kelantan, an increasing number of DENV and chikungunya virus (CHIKV) new cases have been reported, including several deaths. This study aimed to isolate and detect these arboviruses from adult mosquitoes in Kelantan. METHODS: Adult mo squito samples were collected from January to August 2019 and were identified according to gender, species and locality. The isolation of the virus was done in C6/36 cells. Dengue NS1 antigen was carried out using direct mosquito lysate and mosquito culture supernatant. Detection and serotyping of the DENV was performed using multiplex RT-PCR and CHIKV detection using a one-step RT-PCR assay. RESULTS: Of 91 mosquito pools, four were positive for NS1 antigen comprising two pools (2.2%) of male Ae. albopictus (Pulau Melaka and Kubang Siput) and two pools (2.2%) of Ae. aegypti (Kampung Demit Sungai). DENV 1 was detected in one pool (0.9%) of female Ae. albopictus among 114 tested Aedes pools. Two pools of 114 pools (1.7%) from both male Aedes species were positive with double serotypes, DENV 1 and DENV 2 (Pulau Melaka). However, no pool was positive for CHIKV. INTERPRETATION CONCLUSION: The presence of DENV and the main vectors of arboviruses in Kelantan are pertinent indicators of the need to improve vector controls to reduce arbovirus infections among people in the localities.


Subject(s)
Aedes , Chikungunya virus , Dengue Virus , Dengue , Mosquito Vectors , Animals , Malaysia , Dengue Virus/genetics , Dengue Virus/isolation & purification , Dengue Virus/classification , Chikungunya virus/genetics , Chikungunya virus/isolation & purification , Chikungunya virus/classification , Male , Female , Aedes/virology , Mosquito Vectors/virology , Dengue/virology , Chikungunya Fever/virology , Humans , Viral Nonstructural Proteins/genetics , Serogroup
7.
Nat Commun ; 15(1): 3508, 2024 Apr 25.
Article in English | MEDLINE | ID: mdl-38664380

ABSTRACT

Dengue is the most prevalent mosquito-borne viral disease in humans, and cases are continuing to rise globally. In particular, islands in the Caribbean have experienced more frequent outbreaks, and all four dengue virus (DENV) serotypes have been reported in the region, leading to hyperendemicity and increased rates of severe disease. However, there is significant variability regarding virus surveillance and reporting between islands, making it difficult to obtain an accurate understanding of the epidemiological patterns in the Caribbean. To investigate this, we used travel surveillance and genomic epidemiology to reconstruct outbreak dynamics, DENV serotype turnover, and patterns of spread within the region from 2009-2022. We uncovered two recent DENV-3 introductions from Asia, one of which resulted in a large outbreak in Cuba, which was previously under-reported. We also show that while outbreaks can be synchronized between islands, they are often caused by different serotypes. Our study highlights the importance of surveillance of infected travelers to provide a snapshot of local introductions and transmission in areas with limited local surveillance and suggests that the recent DENV-3 introductions may pose a major public health threat in the region.


Subject(s)
Dengue Virus , Dengue , Disease Outbreaks , Serogroup , Travel , Dengue Virus/genetics , Dengue Virus/classification , Dengue Virus/isolation & purification , Dengue/epidemiology , Dengue/virology , Dengue/transmission , Humans , Caribbean Region/epidemiology , Travel/statistics & numerical data , Phylogeny , Epidemiological Monitoring
8.
Viruses ; 16(4)2024 04 12.
Article in English | MEDLINE | ID: mdl-38675935

ABSTRACT

In 2023, Nepal faced its second largest dengue outbreak ever, following a record-breaking number of dengue cases in 2022, characterized by the expansion of infections into areas of higher altitudes. However, the characteristics of the 2023 circulating dengue virus (DENV) and the vector density remain poorly understood. Therefore, we performed DENV serotyping, clinical and laboratory assessment, and entomological analysis of the 2023 outbreak in central Nepal. A total of 396 fever cases in Dhading hospital suspected of being DENV positive were enrolled, and blood samples were collected and tested by different techniques including PCR. Of these, 278 (70.2%) had confirmed DENV infection. Multiple serotypes (DENV-1, -2, and -3) were detected. DENV-2 (97.5%) re-emerged after six years in Dhading while DENV-3 was identified for the first time. Dengue inpatients had significantly higher frequency of anorexia, myalgia, rash, diarrhea, nausea, vomiting, abdominal pain, and thrombocytopenia (p < 0.05). In this area, Aedes mosquitoes largely predominated (90.7%) with the majority being A. aegypti (60.7%). We also found high levels of Aedes index (20.0%) and container index (16.7%). We confirmed multiple DENV serotype circulation with serotype re-emergence and new serotype introduction, and high vector density in 2023. These findings call for the urgent initiation and scaling up of DENV molecular surveillance in human and mosquito populations for dengue control and prevention in Nepal.


Subject(s)
Aedes , Dengue Virus , Dengue , Disease Outbreaks , Mosquito Vectors , Serogroup , Nepal/epidemiology , Dengue/epidemiology , Dengue/virology , Humans , Dengue Virus/genetics , Dengue Virus/classification , Dengue Virus/isolation & purification , Animals , Aedes/virology , Male , Female , Mosquito Vectors/virology , Adult , Adolescent , Middle Aged , Young Adult , Child , Serotyping , Child, Preschool , Phylogeny
9.
Viruses ; 16(4)2024 04 18.
Article in English | MEDLINE | ID: mdl-38675971

ABSTRACT

The majority of cases of undifferentiated acute febrile illness (AFI) in the tropics have an undefined etiology. In Thailand, AFI accounts for two-thirds of illnesses reported to the Ministry of Public Health. To characterize the bacterial and viral causes of these AFIs, we conducted molecular pathogen screening and serological analyses in patients who sought treatment in Chum Phae Hospital, Khon Kaen province, during the period from 2015 to 2016. Through integrated approaches, we successfully identified the etiology in 25.5% of cases, with dengue virus infection being the most common cause, noted in 17% of the study population, followed by scrub typhus in 3.8% and rickettsioses in 6.8%. Further investigations targeting viruses in patients revealed the presence of Guadeloupe mosquito virus (GMV) in four patients without other pathogen co-infections. The characterization of four complete genome sequences of GMV amplified from AFI patients showed a 93-97% nucleotide sequence identity with GMV previously reported in mosquitoes. Nucleotide substitutions resulted in amino acid differences between GMV amplified from AFI patients and mosquitoes, observed in 37 positions. However, these changes had undergone purifying selection pressure and potentially had a minimal impact on protein function. Our study suggests that the GMV strains identified in the AFI patients are relatively similar to those previously reported in mosquitoes, highlighting their potential role associated with febrile illness.


Subject(s)
Dengue , Fever , Humans , Thailand/epidemiology , Female , Male , Middle Aged , Adult , Dengue/virology , Dengue/epidemiology , Fever/virology , Young Adult , Adolescent , Phylogeny , Aged , Child , Scrub Typhus/microbiology , Scrub Typhus/epidemiology , Scrub Typhus/virology , Bacteria/genetics , Bacteria/isolation & purification , Bacteria/classification , Child, Preschool , Coinfection/virology , Coinfection/microbiology , Coinfection/epidemiology , Viruses/genetics , Viruses/classification , Viruses/isolation & purification , Culicidae/virology , Culicidae/microbiology , Animals , Dengue Virus/genetics , Dengue Virus/classification , Dengue Virus/isolation & purification , Rickettsia Infections/epidemiology , Rickettsia Infections/microbiology , Rickettsia Infections/virology
10.
J Vector Borne Dis ; 61(1): 117-122, 2024 Jan 01.
Article in English | MEDLINE | ID: mdl-38648413

ABSTRACT

BACKGROUND OBJECTIVES: This study reports observation on circulating serotypes and genotypes of Dengue Virus in North India. METHODS: Serum samples were obtained from suspected cases of dengue referred to the virus diagnostic laboratory during 2014 to 2022. All samples were tested for anti-dengue virus IgM antibodies and NS1Ag by ELISA. NS1Ag positive samples were processed for serotyping and genotyping. RESULTS: Total 41,476 dengue suspected cases were referred to the laboratory of which 12,292 (29.6%) tested positive. Anti-Dengue Virus IgM antibodies, NS1Ag, both IgM and NS1Ag, were positive in 7007 (57.4%); 3200 (26.0%) and 2085 (16.0%) cases respectively. Total 762 strains were serotyped during 9-year period. DENV-1, DENV-2, DENV-3 and DENV-4 serotypes were found in 79 (10.37%), 506 (66.40%), 151 (19.82%) and 26 (3.41%) cases respectively. DENV-1, DENV-2 and DENV-3 were in circulation throughout. Total 105 strains were genotyped. Genotype IV of DENV-1 serotype was circulating till 2014 which was later replaced by genotype V. A distinct seasonality with increase in number of cases in post-monsoon period was seen. INTERPRETATION CONCLUSION: DENV-1, DENV-2 and DENV-3 were found to be in circulation in North India. Predominant serotype/genotype changed at times, but not at regular intervals.


Subject(s)
Antibodies, Viral , Dengue Virus , Dengue , Genotype , Serogroup , India/epidemiology , Dengue Virus/genetics , Dengue Virus/classification , Dengue Virus/isolation & purification , Humans , Dengue/virology , Dengue/epidemiology , Dengue/blood , Antibodies, Viral/blood , Immunoglobulin M/blood , Female , Serotyping , Male , Adult , Child , Enzyme-Linked Immunosorbent Assay , Adolescent , Middle Aged , Young Adult , Seasons , Child, Preschool
11.
Travel Med Infect Dis ; 59: 102699, 2024.
Article in English | MEDLINE | ID: mdl-38452991

ABSTRACT

Dengue virus (DENV) is one of the most significant vector-borne pathogens worldwide. In this report, we describe clinical features and laboratory detection of dengue in a 45-year-old traveler to Nicaragua on return home to the United States in 2019. Clinical presentation was mild, with rash, headache, and fatigue, with only low-grade transient fever. Infection dynamics were documented by serology and PCR of serially collected body fluids. DENV serotype 2 was detected in whole blood 1 day after symptoms emerged, with viral RNA isolated to the red cell fraction, and remained detectable through day 89. DENV-2 RNA was detected in serum only on day 4, and IgM was undetectable on day 4 but evident by day 13. Viral RNA was also detected in urine. This report of DENV-2 RNA persistence in blood cells but only transient appearance in serum, supports the potential diagnostic value of whole blood over serum for PCR and opportunity of an expanded testing window. Informed testing approaches can improve diagnostic accuracy and inform strategies that preserve individual and public health.


Subject(s)
Dengue Virus , Dengue , RNA, Viral , Travel , Humans , Dengue Virus/genetics , Dengue Virus/isolation & purification , Dengue/virology , Dengue/diagnosis , Dengue/blood , RNA, Viral/blood , Middle Aged , Nicaragua , Male , Serogroup , Immunoglobulin M/blood
12.
Microbiol Spectr ; 11(1): e0279622, 2023 02 14.
Article in English | MEDLINE | ID: mdl-36682882

ABSTRACT

The efficient and accurate diagnosis of dengue, a major mosquito-borne disease, is of primary importance for clinical care, surveillance, and outbreak control. The identification of specific dengue virus serotype 1 (DENV-1) to DENV-4 can help in understanding the transmission dynamics and spread of dengue disease. The four rapid low-resource serotype-specific dengue tests use a simple sample preparation reagent followed by reverse transcription-isothermal recombinase polymerase amplification (RT-RPA) combined with lateral flow detection (LFD) technology. Results are obtained directly from clinical sample matrices in 35 min, requiring only a heating block and pipettes for liquid handling. In addition, we demonstrate that the rapid sample preparation step inactivates DENV, improving laboratory safety. Human plasma and serum were spiked with DENV, and DENV was detected with analytical sensitivities of 333 to 22,500 median tissue culture infectious doses (TCID50)/mL. The analytical sensitivities in blood were 94,000 to 333,000 TCID50/mL. Analytical specificity testing confirmed that each test could detect multiple serotype-specific strains but did not respond to strains of other serotypes, closely related flaviviruses, or chikungunya virus. Clinical testing on 80 human serum samples demonstrated test specificities of between 94 and 100%, with a DENV-2 test sensitivity of 100%, detecting down to 0.004 PFU/µL, similar to the sensitivity of the PCR test; the other DENV tests detected down to 0.03 to 10.9 PFU/µL. Collectively, our data suggest that some of our rapid dengue serotyping tests provide a potential alternative to conventional labor-intensive RT-quantitative PCR (RT-qPCR) detection, which requires expensive thermal cycling instrumentation, technical expertise, and prolonged testing times. Our tests provide performance and speed without compromising specificity in human plasma and serum and could become promising tools for the detection of high DENV loads in resource-limited settings. IMPORTANCE The efficient and accurate diagnosis of dengue, a major mosquito-borne disease, is of primary importance for clinical care, surveillance, and outbreak control. This study describes the evaluation of four rapid low-resource serotype-specific dengue tests for the detection of specific DENV serotypes in clinical sample matrices. The tests use a simple sample preparation reagent followed by reverse transcription-isothermal recombinase polymerase amplification (RT-RPA) combined with lateral flow detection (LFD) technology. These tests have several advantages compared to RT-qPCR detection, such as a simple workflow, rapid sample processing and turnaround times (35 min from sample preparation to detection), minimal equipment needs, and improved laboratory safety through the inactivation of the virus during the sample preparation step. The low-resource formats of these rapid dengue serotyping tests have the potential to support effective dengue disease surveillance and enhance the diagnostic testing capacity in resource-limited countries with both endemic dengue and intense coronavirus disease 2019 (COVID-19) transmission.


Subject(s)
Dengue Virus , Dengue , Humans , Dengue/diagnosis , Dengue Virus/classification , Dengue Virus/isolation & purification , Rapid Diagnostic Tests , Recombinases , Sensitivity and Specificity , Serogroup
13.
PLoS Negl Trop Dis ; 16(2): e0010206, 2022 02.
Article in English | MEDLINE | ID: mdl-35139066

ABSTRACT

The tiger mosquito was introduced to the Eastern region of the Mediterranean basin more than twenty years ago. In Lebanon, it was first observed in 2002 in a limited number of locations mainly from the coastal area of the country. In the absence of national entomological control program, this invasive mosquito became an established species and is now considered in many localities, a source of nuisance because of its human biting behavior. Several entomological surveys were conducted to monitor the geographic spread and the seasonal dynamics of Aedes albopictus by collecting adult stages and by monitoring oviposition activity. Moreover, its susceptibility to the common groups of insecticides was assessed using WHO standard bioassays. Previous vector competence studies revealed that local strains were able to transmit Chikungunya and Dengue viruses. Due to the increased risk of Zika virus introduction in the country, we determined the competence of local populations to transmit this virus. Mapping results showed that Ae. albopictus is mainly spread in the relatively humid western versant of the Mount Lebanon chain reaching 1000m altitude, while it is absent from arid and semi-arid inland areas. Besides, this mosquito is active during 32 weeks from spring till the end of autumn. Local strains of the tiger mosquito are susceptible to pyrethroids and carbamates but resistant to organophosphates and organochlorines. They showed ability to transmit Zika virus; however, only 9% of females were capable to excrete the virus in their saliva at day 28 post infection. Current and previous observations highlight the need to establish a surveillance system in order to control this mosquito and monitor the potential introduction of related diseases.


Subject(s)
Aedes/physiology , Introduced Species/statistics & numerical data , Mosquito Vectors/physiology , Aedes/drug effects , Aedes/virology , Animal Distribution , Animals , Dengue Virus/genetics , Dengue Virus/isolation & purification , Female , Insecticides/pharmacology , Lebanon , Male , Mosquito Vectors/drug effects , Mosquito Vectors/virology , Pyrethrins/pharmacology , Saliva/virology , Seasons , Zika Virus/genetics , Zika Virus/isolation & purification
14.
PLoS Negl Trop Dis ; 16(2): e0009848, 2022 02.
Article in English | MEDLINE | ID: mdl-35143495

ABSTRACT

Across the Pacific, and including in the Solomon Islands, outbreaks of arboviruses such as dengue, chikungunya, and Zika are increasing in frequency, scale and impact. Outbreaks of mosquito-borne disease have the potential to overwhelm the health systems of small island nations. This study mapped the seroprevalence of dengue, Zika, chikungunya and Ross River viruses in 5 study sites in the Solomon Islands. Serum samples from 1,021 participants were analysed by ELISA. Overall, 56% of participants were flavivirus-seropositive for dengue (28%), Zika (1%) or both flaviviruses (27%); and 53% of participants were alphavirus-seropositive for chikungunya (3%), Ross River virus (31%) or both alphaviruses (18%). Seroprevalence for both flaviviruses and alphaviruses varied by village and age of the participant. The most prevalent arboviruses in the Solomon Islands were dengue and Ross River virus. The high seroprevalence of dengue suggests that herd immunity may be a driver of dengue outbreak dynamics in the Solomon Islands. Despite being undetected prior to this survey, serology results suggest that Ross River virus transmission is endemic. There is a real need to increase the diagnostic capacities for each of the arboviruses to support effective case management and to provide timely information to inform vector control efforts and other outbreak mitigation interventions.


Subject(s)
Alphavirus Infections/blood , Chikungunya Fever/blood , Chikungunya virus/immunology , Dengue Virus/immunology , Dengue/blood , Ross River virus/immunology , Zika Virus Infection/blood , Zika Virus/immunology , Adolescent , Adult , Aged , Aged, 80 and over , Alphavirus Infections/epidemiology , Alphavirus Infections/virology , Antibodies, Viral/blood , Chikungunya Fever/epidemiology , Chikungunya Fever/virology , Chikungunya virus/genetics , Chikungunya virus/isolation & purification , Child , Child, Preschool , Dengue/epidemiology , Dengue/virology , Dengue Virus/genetics , Dengue Virus/isolation & purification , Female , Humans , Male , Melanesia/epidemiology , Middle Aged , Ross River virus/genetics , Ross River virus/isolation & purification , Seroepidemiologic Studies , Young Adult , Zika Virus/genetics , Zika Virus/isolation & purification , Zika Virus Infection/epidemiology , Zika Virus Infection/virology
15.
Viruses ; 14(2)2022 01 24.
Article in English | MEDLINE | ID: mdl-35215813

ABSTRACT

The transmission of dengue and other medically important mosquito-borne viruses in the westernmost region of Indonesia is not well described. We assessed dengue and Zika virus seroprevalence in Aceh province, the westernmost area of the Indonesian archipelago. Serum samples collected from 199 randomly sampled healthy residents of Aceh Jaya in 2017 were analyzed for neutralizing antibodies by plaque reduction neutralization test (PRNT). Almost all study participants (198/199; 99.5%) presented with multitypic profiles of neutralizing antibodies to two or more DENV serotypes, indicating transmission of multiple DENV in the region prior to 2017. All residents were exposed to one or more DENV serotypes by the age of 30 years. The highest geometric mean titers were measured for DENV-4, followed by DENV-1, DENV-2 and DENV-3. Among a subset of 116 sera, 27 neutralized ZIKV with a high stringency (20 with PRNT90 > 10 and 7 with PRNT90 > 40). This study showed that DENV is hyperendemic in the westernmost region of the Indonesian archipelago and suggested that ZIKV may have circulated prior to 2017.


Subject(s)
Antibodies, Viral/blood , Dengue Virus/immunology , Dengue/blood , Zika Virus Infection/blood , Zika Virus/immunology , Adolescent , Adult , Aged , Child , Child, Preschool , Dengue/epidemiology , Dengue/virology , Dengue Virus/classification , Dengue Virus/genetics , Dengue Virus/isolation & purification , Female , Humans , Indonesia/epidemiology , Male , Middle Aged , Neutralization Tests , Seroepidemiologic Studies , Young Adult , Zika Virus/classification , Zika Virus/genetics , Zika Virus/isolation & purification , Zika Virus Infection/epidemiology , Zika Virus Infection/virology
16.
Viruses ; 14(1)2022 01 06.
Article in English | MEDLINE | ID: mdl-35062303

ABSTRACT

Dengue is a mosquito-borne disease of public health concern affecting tropical and subtropical countries, including Indonesia. Although studies on dengue epidemiology have been undertaken in Indonesia, data are lacking in many areas of the country. The aim of this study was to determine dengue virus (DENV) and chikungunya virus (CHIKV) molecular epidemiology in western regions of the Indonesian archipelago. A one-year prospective study was conducted in Aceh and Jambi in 2015 and 2016, respectively, where patients with dengue-like illness were enrolled. Of 205 patients recruited, 29 and 27 were confirmed with dengue in Aceh and Jambi, respectively, and three from Jambi were confirmed with chikungunya. DENV-1 was the predominant serotype identified in Aceh while DENV-2 was predominant in Jambi. All DENV-1 and DENV-2 from both regions were classified as Genotype I and Cosmopolitan genotype, respectively, and all DENV-3 viruses from Jambi were Genotype I. Some viruses, in particular DENV-1, displayed a distinct lineage distribution, where two DENV-1 lineages from Aceh were more closely related to viruses from China instead of Jambi highlighting the role of travel and flight patterns on DENV transmission in the region. DENV-2 from both Aceh and Jambi and DENV-3 from Jambi were all closely related to Indonesian local strains. All three CHIKV belonged to Asian genotype and clustered closely with Indonesian CHIKV strains including those previously circulating in Jambi in 2015, confirming continuous and sustainable transmission of CHIKV in the region. The study results emphasize the importance of continuous epidemiological surveillance of arboviruses in Indonesia and simultaneous testing for CHIKV among dengue-suspected patients.


Subject(s)
Chikungunya Fever/epidemiology , Chikungunya virus/genetics , Dengue Virus/genetics , Dengue/epidemiology , Adolescent , Adult , Chikungunya Fever/virology , Chikungunya virus/isolation & purification , Child , Child, Preschool , Cross-Sectional Studies , Dengue/virology , Dengue Virus/isolation & purification , Female , Genotype , Humans , Indonesia/epidemiology , Infant , Male , Middle Aged , Molecular Epidemiology , Phylogeny , Serogroup , Young Adult
17.
PLoS One ; 17(1): e0262785, 2022.
Article in English | MEDLINE | ID: mdl-35041718

ABSTRACT

Dengue viral (DENV) infections can lead to acute pancreatitis and associated tissue damage. This study examined the pancreas from two fatal cases of DENV for histopathological changes as well as for the detection of cytokines, and other inflammatory mediators. Tissue sections were prepared for examination by ultrastructural and histopathological techniques. Sections from the pancreas of non-infected individuals were prepared in parallel as a control. The presence of viral replication in macrophages was detected by co-staining for the proteins NS3 and CD68 by immunofluorescence. Immunohistochemistry was used to detect cells that expressed cytokines and inflammatory mediators to characterize the inflammatory response. Edema, acinar necrosis and fibrosis areas associated with a mononuclear infiltrate were found in infected tissues. The major site of virus replication appeared to be macrophages based on their exclusive presentation of the viral protein NS3. Pancreatic tissues from the infected individuals also displayed increased levels of high mobility group box-1, caspase-3, gelatinase B and tumor necrosis factor alpha compared to controls. The presence of virus replicating macrophages in the pancreas was associated with multiple changes in tissue structure that included elevated levels of cytokines and inflammatory markers that may differentiate acute pancreatitis due to DENV infections from other causes.


Subject(s)
Biomarkers/metabolism , Cytokines/metabolism , Dengue Virus/isolation & purification , Dengue/complications , Inflammation Mediators/metabolism , Pancreatitis/pathology , Adult , Apoptosis , Dengue/virology , Female , Humans , Male , Middle Aged , Pancreatitis/metabolism , Pancreatitis/virology , Young Adult
18.
PLoS Negl Trop Dis ; 16(1): e0010084, 2022 01.
Article in English | MEDLINE | ID: mdl-35015769

ABSTRACT

Dengue fever is one of the most severe viral diseases transmitted by Aedes mosquitoes, with traditional approaches of disease control proving insufficient to prevent significant disease burden. Release of Wolbachia-transinfected mosquitoes offers a promising alternative control methodologies; Wolbachia-transinfected female Aedes aegypti demonstrate reduced dengue virus transmission, whilst Wolbachia-transinfected males cause zygotic lethality when crossed with uninfected females, providing a method for suppressing mosquito populations. Although highly promising, the delicate nature of population control strategies and differences between local species populations means that controlled releases of Wolbachia-transinfected mosquitoes cannot be performed without extensive testing on specific local Ae. aegypti populations. In order to investigate the potential for using Wolbachia to suppress local Ae. aegypti populations in Taiwan, we performed lab-based and semi-field fitness trials. We first transinfected the Wolbachia strain wAlbB into a local Ae. aegypti population (wAlbB-Tw) and found no significant changes in lifespan, fecundity and fertility when compared to controls. In the laboratory, we found that as the proportion of released male mosquitoes carrying Wolbachia was increased, population suppression could reach up to 100%. Equivalent experiments in semi-field experiments found suppression rates of up to 70%. The release of different ratios of wAlbB-Tw males in the semi-field system provided an estimate of the optimal size of male releases. Our results indicate that wAlbB-Tw has significant potential for use in vector control strategies aimed at Ae. aegypti population suppression in Taiwan. Open field release trials are now necessary to confirm that wAlbB-Tw mediated suppression is feasible in natural environments.


Subject(s)
Aedes/microbiology , Dengue/prevention & control , Mosquito Control/methods , Pest Control, Biological/methods , Wolbachia/metabolism , Animals , Biological Control Agents/administration & dosage , Dengue/transmission , Dengue Virus/isolation & purification , Female , Male , Mosquito Vectors/virology , Taiwan , Wolbachia/classification , Zygote/microbiology
19.
J Med Virol ; 94(2): 540-548, 2022 02.
Article in English | MEDLINE | ID: mdl-34730296

ABSTRACT

For the past several decades, dengue fever has been emerging in epidemic proportions in several regions of the world. During August-September 2019, an increasing number of fever cases were being reported from some areas of North 24 Parganas district of West Bengal, India. Accordingly, outbreak investigation of fever cases from these affected areas of Bongoan, Barasat, and Habra was carried out. To characterize clinical and biochemical features of fever cases as well as to investigate the utility of CRP as a Dengue severity marker in resource-limited settings. We systematically enrolled 108 patients from the affected region of North 24 Parganas. Standard diagnostic assays along with routine serological and biochemical parameters were performed. Of the 108 patients, 77 (71%) were confirmed with Dengue infection followed by 22 (20%) DENV seronegative and 9 (8%) coinfected DENV cases. Among the 77 confirmed Dengue patients, 53 (69%) had primary infection while 24 (31%) had secondary infection. Among the DENV clinical symptoms, fever (r = 0.50; p = 0.004), headache (r = 0.40; p = 0.03) and abdominal pain (r = -0.40; p = 0.02) were found to bear significant correlation with DENV viral load. The predominant circulating serotype was found to be DENV2. CRP Dengue severity cut-off level of 10.15 mg/L (AUC: 0.85; 86% sensitivity, 77% specificity) was obtained. CRP had correlation with viral load (r = 0.4, p = 0.05) within febrile phase of infection. The performance of biomarkers can be influenced by local epidemiology, geography, and several patient factors, therefore, CRP Dengue severity cut-off value may be region-specific. This study for the first time attempts to estimate CRP Dengue severity cut-off value based on routine immunoturbidometric evaluation from Dengue Hyperendemic zones of North 24 Parganas, West Bengal, Eastern India.


Subject(s)
C-Reactive Protein/analysis , Dengue Virus/isolation & purification , Dengue/epidemiology , Fever/epidemiology , Adult , Antibodies, Viral/blood , Coinfection/epidemiology , Dengue/blood , Dengue/virology , Dengue Virus/genetics , Dengue Virus/immunology , Female , Humans , India/epidemiology , Male , Serogroup , Viral Load , Young Adult
20.
J Med Virol ; 94(1): 393-398, 2022 01.
Article in English | MEDLINE | ID: mdl-34436792

ABSTRACT

Dengue virus and severe acute respiratory syndrome coronavirus 2 coexist in dengue-endemic countries; therefore, the adoption of preventive measures is essential to control the spread of both viruses. We conducted an ecological study to compare the temporal patterns of the incidence of dengue before and during the Coronavirus disease 2019 (COVID-19) pandemic in Peru. A time-series analysis comparing the incidence of dengue using a Student's t test with variance correction was performed. Poisson regression was applied to determine the incidence rate ratio (IRR) of dengue before and during the COVID-19 pandemic. The incidence of dengue was found to be increased in all endemic regions of Peru during the COVID-19 pandemic, with the highest incidences registered in Ica (IRR = 90.14), Huánuco (IRR = 38.6), and Ucayali (IRR = 23.78), with the exception of Piura (IRR = 0.83). The highest increases in the number of dengue cases per million inhabitants were in Ucayali (393.38), Tumbes (233.19), Ica (166.08), and Loreto (129.93). The gradient of dengue cases was positive in all endemic regions during the COVID-19 pandemic. The number of dengue cases per million increased during the COVID-19 pandemic throughout Peru and in several endemic regions, with the exception of Piura.


Subject(s)
COVID-19/epidemiology , Coinfection/epidemiology , Dengue/epidemiology , Dengue Virus/isolation & purification , Geography , Humans , Incidence , Peru/epidemiology , SARS-CoV-2/isolation & purification , Vector Borne Diseases/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL
...